These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 6824120)

  • 1. Original antigenic sin in dengue.
    Halstead SB; Rojanasuphot S; Sangkawibha N
    Am J Trop Med Hyg; 1983 Jan; 32(1):154-6. PubMed ID: 6824120
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors in dengue shock syndrome: a prospective epidemiologic study in Rayong, Thailand. I. The 1980 outbreak.
    Sangkawibha N; Rojanasuphot S; Ahandrik S; Viriyapongse S; Jatanasen S; Salitul V; Phanthumachinda B; Halstead SB
    Am J Epidemiol; 1984 Nov; 120(5):653-69. PubMed ID: 6496446
    [TBL] [Abstract][Full Text] [Related]  

  • 3. B Cell Responses during Secondary Dengue Virus Infection Are Dominated by Highly Cross-Reactive, Memory-Derived Plasmablasts.
    Priyamvada L; Cho A; Onlamoon N; Zheng NY; Huang M; Kovalenkov Y; Chokephaibulkit K; Angkasekwinai N; Pattanapanyasat K; Ahmed R; Wilson PC; Wrammert J
    J Virol; 2016 Jun; 90(12):5574-85. PubMed ID: 27030262
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A prospective seroepidemiologic study on dengue in children four to nine years of age in Yogyakarta, Indonesia I. studies in 1995-1996.
    Graham RR; Juffrie M; Tan R; Hayes CG; Laksono I; Ma'roef C; Erlin ; Sutaryo ; Porter KR; Halstead SB
    Am J Trop Med Hyg; 1999 Sep; 61(3):412-9. PubMed ID: 10497982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dengue virus cross-reactive hemagglutination inhibition antibody responses in patients with primary dengue virus infection.
    Anantapreecha S; A-Nuegoonpipat A; Prakrong S; Chanama S; Sa-Ngasang A; Sawanpanyalert P; Kurane I
    Jpn J Infect Dis; 2007 Sep; 60(5):267-70. PubMed ID: 17881865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serological and virological studies on patients with dengue hemorrhagic fever (DHF) in Chanthaburi province, Thailand. I. Serological studies on paired sera from DHF patients by neutralization (N), hemagglutination inhibition (HI) and staining tests.
    Okuno Y; Fukunaga T; Srisupaluck S; Kasemsarn P; Dharakul C; Sangkawibha N
    Biken J; 1980 Sep; 23(3):113-21. PubMed ID: 7458894
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Shock syndrome in primary dengue infections.
    Scott RM; Nimmannitya S; Bancroft WH; Mansuwan P
    Am J Trop Med Hyg; 1976 Nov; 25(6):866-74. PubMed ID: 1008131
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dissecting the human serum antibody response to secondary dengue virus infections.
    Patel B; Longo P; Miley MJ; Montoya M; Harris E; de Silva AM
    PLoS Negl Trop Dis; 2017 May; 11(5):e0005554. PubMed ID: 28505154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibody avidity following secondary dengue virus type 2 infection across a range of disease severity.
    Lau L; Green AM; Balmaseda A; Harris E
    J Clin Virol; 2015 Aug; 69():63-7. PubMed ID: 26209381
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High frequency of pre-existing neutralizing antibody responses in patients with dengue during an outbreak in Central Brazil.
    de Teive E Argolo AF; de Rezende Féres VC; Cordeiro MT; da Silveira LA; Guilarde AO; de Azevedo Marques ET; de Souza WV; Martelli CM
    BMC Infect Dis; 2016 Oct; 16(1):546. PubMed ID: 27717314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A rapid fluorescent focus-inhibition test for determining dengue neutralizing antibody and for identifying prototype dengue viruses.
    Thacker WL; Lewis VJ; Baer GM; Sather GE
    Can J Microbiol; 1978 Dec; 24(12):1553-6. PubMed ID: 747816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence that maternal dengue antibodies are important in the development of dengue hemorrhagic fever in infants.
    Kliks SC; Nimmanitya S; Nisalak A; Burke DS
    Am J Trop Med Hyg; 1988 Mar; 38(2):411-9. PubMed ID: 3354774
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibody responses determined for Japanese dengue fever patients by neutralization and hemagglutination inhibition assays demonstrate cross-reactivity between dengue and Japanese encephalitis viruses.
    Yamada K; Takasaki T; Nawa M; Yabe S; Kurane I
    Clin Diagn Lab Immunol; 2003 Jul; 10(4):725-8. PubMed ID: 12853413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunity and immunopathology in dengue virus infections.
    Kurane I; Ennis FE
    Semin Immunol; 1992 Apr; 4(2):121-7. PubMed ID: 1617166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protective Capacity of the Human Anamnestic Antibody Response during Acute Dengue Virus Infection.
    Xu M; Züst R; Toh YX; Pfaff JM; Kahle KM; Davidson E; Doranz BJ; Velumani S; Tukijan F; Wang CI; Fink K
    J Virol; 2016 Dec; 90(24):11122-11131. PubMed ID: 27707930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship of preexisting dengue virus (DV) neutralizing antibody levels to viremia and severity of disease in a prospective cohort study of DV infection in Thailand.
    Endy TP; Nisalak A; Chunsuttitwat S; Vaughn DW; Green S; Ennis FA; Rothman AL; Libraty DH
    J Infect Dis; 2004 Mar; 189(6):990-1000. PubMed ID: 14999601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of cross-reactive antibodies to plasminogen during the immune response to dengue virus infection.
    Markoff LJ; Innis BL; Houghten R; Henchal LS
    J Infect Dis; 1991 Aug; 164(2):294-301. PubMed ID: 1856477
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation by flow cytometry of antibody-dependent enhancement (ADE) of dengue infection by sera from Thai children immunized with a live-attenuated tetravalent dengue vaccine.
    Guy B; Chanthavanich P; Gimenez S; Sirivichayakul C; Sabchareon A; Begue S; Yoksan S; Luxemburger C; Lang J
    Vaccine; 2004 Sep; 22(27-28):3563-74. PubMed ID: 15315835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complexity of Neutralizing Antibodies against Multiple Dengue Virus Serotypes after Heterotypic Immunization and Secondary Infection Revealed by In-Depth Analysis of Cross-Reactive Antibodies.
    Tsai WY; Durbin A; Tsai JJ; Hsieh SC; Whitehead S; Wang WK
    J Virol; 2015 Jul; 89(14):7348-62. PubMed ID: 25972550
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Placental passage of antibodies to Dengue virus in persons living in a region of hyperendemic Dengue virus infection.
    Ventura AK; Ehrenkranz NJ; Rosenthal D
    J Infect Dis; 1975 May; 131 Suppl():S62-8. PubMed ID: 805190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.